Regulation A · Tier 1 · CBDL
CBD Life Sciences Inc.
CBD Life Sciences Inc. (CBDL) filed a Tier 1 Regulation A offering statement (Form 1-A) on May 22, 2019 for up to $2M at $0.0005 per security. The SEC qualified the offering on Mar 11, 2020.
- Status
- Qualified
- Tier
- Tier 1
- Offering size
- $2M
- Offer price
- $0.0005
- Security type
- Equity (common or preferred stock)
- Filed
- May 22, 2019
- Qualified
- Mar 11, 2020
- Ticker
- CBDL
- Exchange
- OTC
- Industry
- Medicinal Chemicals & Botanical Products
- State
- AZ
More on this offering for subscribers
- Revenue, net income and total assets from the offering statement
- Employees
- Market cap at the offer price
- Amount raised, from the exit report (Form 1-Z)
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
Other qualified Biotech & pharma Reg A offerings
- Cytonics CorpJul 6, 2020 · $19M
- Bioquest CorpMay 22, 2020 · $1M
- Verax Research Services, Inc.May 4, 2020 · $50M
- Mystic Holdings Inc./NVMar 20, 2020 · $50M
- Quadrant Biosciences IncMar 9, 2020 · $15M
- Scopus BioPharma Inc.Feb 4, 2020 · $1M